Prostatic Neoplasms
Showing NaN - NaN of 22
Prostatic Tumors, Psychological Distress, Physician-Patient Relations Trial in Laval, Montréal, Québec (Let's Discuss Health
Recruiting
- Prostatic Neoplasms
- +6 more
- Let's Discuss Health Group
-
Laval, Quebec, Canada
- +2 more
Mar 24, 2023
Prostatic Tumors, Tumor Metastasis, Urogenital Tumors Trial in Worldwide (Abemaciclib, Abiraterone, Prednisone or Prednisolone)
Recruiting
- Prostatic Neoplasms
- +16 more
- Abemaciclib
- +3 more
-
Birmingham, Alabama
- +296 more
Jan 18, 2023
Prostatic Tumors Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223), Matching (normal saline), Abiraterone)
Active, not recruiting
- Prostatic Neoplasms
- Radium-223 dichloride (Xofigo, BAY88-8223)
- +3 more
-
Anchorage, Alaska
- +163 more
Jan 18, 2023
Prostatic Tumors Trial in Worldwide (Apalutamide, Abiraterone acetate, Prednisone)
Active, not recruiting
- Prostatic Neoplasms
- Apalutamide
- +3 more
-
Phoenix, Arizona
- +183 more
Jan 17, 2023
Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial in Worldwide (Abiraterone Acetate, Prednisone,
Active, not recruiting
- Prostatic Neoplasms
- Metastatic Castration-Resistant Prostate Cancer
- Abiraterone Acetate
- +2 more
-
Los Angeles, California
- +6 more
Jan 18, 2023
Prostatic Tumors Trial in Worldwide (Darolutamide (Nubeqa, BAY1841788), Placebo, Androgen deprivation therapy (ADT))
Active, not recruiting
- Prostatic Neoplasms
- Darolutamide (Nubeqa, BAY1841788)
- +2 more
-
Macquarie University, New South Wales, Australia
- +131 more
Jan 5, 2023
Prostatic Tumors Trial in Worldwide (Pembrolizumab, Enzalutamide, Placebo)
Active, not recruiting
- Prostatic Neoplasms
- Pembrolizumab
- +2 more
-
Mobile, Alabama
- +257 more
Nov 22, 2022
Prostate Cancer, Prostate Adenocarcinoma, Prostatic Tumors Trial in Montreal (131I-PSMA-1095 Radioligand Therapy (RLT))
Active, not recruiting
- Prostate Cancer
- +5 more
- 131I-PSMA-1095 Radioligand Therapy (RLT)
-
Montreal, Quebec, CanadaStephan Probst
Oct 24, 2022
Prostatic Tumors Trial in Worldwide (Niraparib)
Active, not recruiting
- Prostatic Neoplasms
-
Tucson, Arizona
- +109 more
Aug 2, 2022
Prostatic Tumors Trial in Worldwide (Enzalutamide, NSAA, LHRHA or Surgical Castration)
Active, not recruiting
- Prostatic Neoplasms
- Enzalutamide
- +2 more
-
Boston, Massachusetts
- +81 more
Oct 7, 2021
Metastatic Cancer of Prostate: A Study of ZYTIGA Use in
Completed
- Prostatic Neoplasms
- Abiraterone Acetate (ZYTIGA): Prostate Cancer Registry
-
Calgary, Alberta, Canada
- +40 more
Dec 5, 2019
Prostatic Tumors Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223))
Completed
- Prostatic Neoplasms
- Radium-223 dichloride (Xofigo, BAY88-8223)
-
Scottsdale, Arizona
- +67 more
Jun 30, 2019
Prostate Cancer, Castration Resistant Prostate Cancer, Pain Trial in Worldwide (cabozantinib, prednisone)
Completed
- Prostate Cancer
- +3 more
-
Birmingham, Alabama
- +263 more
Feb 14, 2018
Prostatic Tumors Trial in Worldwide (Radium-223 dichloride (BAY88-8223))
Completed
- Prostatic Neoplasms
- Radium-223 dichloride (BAY88-8223)
-
Brugge, Belgium
- +214 more
Mar 30, 2017
Prostatic Tumors Trial in Worldwide (Placebo, Abiraterone acetate, Prednisone/prednisolone)
Completed
- Prostatic Neoplasms
- Placebo
- +2 more
-
Birmingham, Alabama
- +127 more
Apr 10, 2014
Colorectal Tumors, Lung Tumors, Breast Tumors Trial in Worldwide (figitumumab, pegvisomant)
Terminated
- Colorectal Neoplasms
- +4 more
-
Minneapolis, Minnesota
- +4 more
Oct 23, 2013
Prostatic Tumors Trial in Worldwide (CP-751,871, docetaxel, prednisone)
